Back to search

France· FR:61253153

RUCONEST 2100 U, poudre et solvant pour solution injectable

A conestat alfa product containing conestat alfa, registered in France by PHARMING GROUP (PAYS-BAS). The same ATC class is registered in 11 of our 19 countries.

ATC B06AC04

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedRUCONEST 2100 U, poudre et solvant po…ATCB06AC04REGISTER NO.FR:61253153PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Conestat alfa is registered in 11 of 19 countries.

Countries holding a registration under ATC B06AC04 (conestat alfa), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 7 of them publish a price we can compare per daily dose

Conestat alfa · ATC B06AC04

11 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
CONESTAT ALFA
Manufacturer
PHARMING GROUP (PAYS-BAS)
Country
France (FR)
ATC code
B06AC04
ATC class
Conestat alfa
Defined daily dose
3.5 TSD, E
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

  • cip13
    3400930142998
    1 flacon de poudre en verre + 1 flacon de solvant en verre + 2 adaptateurs pour flacon + 1 seringue + 1 set de perfusion + 2 lingettes d’alcool +1 compresse stérile +1 pansement

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

47 interactions on record for conestat alfa.

Graded by severity as the source publishes them — 5 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Conestat alfa · interactions on record

47 records

  • 5 severe
  • 42 moderate

Most severe, free to view

  • CarfilzomibL01XG02severe
  • CarfilzomibL01XX45severe
  • ThalidomideL04AX02severe
  • LenalidomideL04AX04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Conestat alfa in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All conestat alfa products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Ruconest
  • Liechtenstein · Ruconest
  • Norway · Ruconest

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f38f219e-8075-4d45-a1e4-065c769893cc
GET /v1/drugs/f38f219e-8075-4d45-a1e4-065c769893cc?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "61253153",
  "date_amm": "2017-01-11",
  "type_amm": "Procédure centralisée",
  "numero_ue": "EU/1/10/641",
  "substance": "CONESTAT ALFA",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": "Warning disponibilité",
  "forme_pharmaceutique": "poudre et  solvant pour solution injectable",
  "voies_administration": "intraveineuse",
  "etat_commercialisation": "Non commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about conestat alfa.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.